Floatz logo

ad1208

Solid Tumor in Advanced Stage

Avelos Therapeutics Inc.Phase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Solid Tumor in Advanced Stage cohort.

Asset / SponsorPhaseRating
Sparc1028
Sun Pharma Advanced Research Company Limited
Phase 1CC
Sparc1023 Ii
Sun Pharma Advanced Research Company Limited
Phase 1CC

Same molecule, other indications

ad1208 is also rated in:

Solid Tumor, Unspecified, AdultDormant
CCC
Indicative ·
48 / 100
View asset →
refractory malignant neoplasmDormant
CCC
Indicative ·
48 / 100
View asset →
neoplasmDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →